Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks to buy or sell: Dharmesh Shah of ICICI Sec suggests buying Shriram Finance, Piramal Pharma shares on 6 July
Indian benchmark indices, Sensex and Nifty 50, opened higher on July 6, driven by gains in private banking stocks following strong quarterly updates from HDFC Bank and Axis Bank. Market breadth was positive with 14 of the 16 major indices in the green.
Benchmarks gain for third day on positive global cues; Nifty closes at 24,271
Key benchmark indices extended gains for a third consecutive session on Friday, supported by positive global cues. Weaker-than-expected US jobs data strengthened expectations of a Federal Reserve interest rate cut at its upcoming policy meeting. The Nifty closed at 24,270.85, led by gains in IT, healthcare and metal stocks. However, profit booking in the second half trimmed intraday gains, while broader markets lagged the benchmark indices.
Rajesh Palviya of Axis Sec suggests JSW Infrastructure, Ind-Swift Laboratories, Welspun Living shares to buy next week
The Indian stock market will remain closed on June 26 for the Muharram holiday. Benchmark indices extended their winning streak ahead of the holiday, with Nifty 50 closing at 24,056 and Sensex at 77,100.47, boosted by easing crude oil prices and supportive measures for the rupee.
Nifty tops 23,850 as oil slump sparks broad-based rally
The key equity benchmark indices extended gains for a second consecutive session on Monday, supported by a sharp decline in crude oil prices and optimism surrounding a US-Iran peace agreement. Buying was broad-based, with most sectoral indices ending in the green. Investor sentiment was further buoyed by strong global cues, a stronger rupee and easing market volatility. The Nifty settled above the 23,850 mark, led by gains in consumer durables and auto stocks. However, pharma and healthcare shares bucked the trend and closed lower.
7 most valued firms' mcap eroded ₹1.25 trn last week, RIL took biggest hit
The combined market valuation of seven of the top-10 most-valued firms eroded by Rs 1.25 lakh crore last week, with Reliance Industries taking the biggest hit, in-line with a bearish trend in equities. Last week, the BSE benchmark Sensex declined 532.4 points, or 0.71 per cent, and the NSE Nifty dipped 181.05 points, or 0.76 per cent. "Persistent FII selling remained the key drag on market sentiment despite supportive developments such as cooling crude oil prices and a recovery in the rupee against the US dollar. Concerns regarding the pace of monsoon advancement also weighed on investor confidence," Santosh Meena, Head of Research at Swastika Investmart Ltd, said. From the top-10 pack, Reliance Industries, Bharti Airtel, Tata Consultancy Services (TCS), Bajaj Finance, Larsen & Toubro, Life Insurance Corporation of India (LIC) and Hindustan Unilever faced erosion from their valuation, while HDFC Bank, ICICI Bank, and State Bank of India were the gainers. The market valuation of ...
Ahead of Market: 10 things that will decide stock market action on Tuesday
Benchmark indices Sensex and Nifty fell for a fourth straight session amid elevated crude oil prices, geopolitical tensions and persistent selling pressure. Market breadth remained weak, technical indicators turned bearish, while select stocks including Wockhardt and NMDC Steel attracted buying interest and hit fresh highs.
Mphasis to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment
The Indian stock market is set to open lower, with the Gift Nifty at 23,882, down 97 points. Benchmark indices fell on profit-taking and rising crude oil prices, leading to cautious sentiment. Nifty 50 faces immediate hurdles at 24,100 and support at 23,800.
Pharma, healthcare stocks drag markets amid volatility; Nifty and Sensex close week in green
The equity benchmark indices closed in the green on Friday (May 22) but could not fully hold intraday gains, with Sensex rising 232 points to 75,415 and Nifty gaining 65 points to 23,719.
Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments Bank
Benchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to continue its consolidation between 23,200 and 23,900. Several companies, including ITC, LIC, Sun Pharma, Maruti Suzuki, and Fino Payments Bank, are in focus due to Q4 results and other developments.
Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?
The Nifty Pharma index has surged nearly 11% over the past month, significantly outperforming the Nifty 50, which declined 3.6% during the same period. On a year-to-date (YTD) basis, the Nifty Pharma index has gained 9.4%, while the benchmark Nifty 50 has fallen by an equal margin.
Selling at higher levels turns 23,800 into key barrier for Nifty: Analysts
Benchmark Nifty closed lower last week. Analysts anticipate continued range-bound trading for Nifty this week. Trading strategies suggest buying on dips and selling on rallies within the 23,800-23,200 range. Specific stock recommendations include Indus Towers, Samvardhana Motherson International, Aditya Birla Capital, Sun Pharmaceutical Industries, and Arvind Limited. Investors are advised to consider these opportunities.
Ruchit Jain of Motilal Oswal suggests Granules India, Nippon Life, and SRF shares to buy for the short term
The Nifty 50 and Sensex increased on May 6, supported by a government credit guarantee scheme for businesses. Investor sentiment improved due to positive earnings reports and falling oil prices, suggesting resilience in markets despite recent challenges.